State Street Corp Has $578.67 Million Stock Holdings in Avantor, Inc. (NYSE:AVTR)

State Street Corp grew its holdings in Avantor, Inc. (NYSE:AVTR) by 58.0% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 22,368,244 shares of the company’s stock after purchasing an additional 8,206,695 shares during the quarter. State Street Corp’s holdings in Avantor were worth $578,666,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Stifel Financial Corp lifted its stake in shares of Avantor by 27.5% in the 3rd quarter. Stifel Financial Corp now owns 50,848 shares of the company’s stock valued at $1,315,000 after purchasing an additional 10,980 shares during the period. Quantinno Capital Management LP lifted its stake in shares of Avantor by 57.5% in the 3rd quarter. Quantinno Capital Management LP now owns 139,901 shares of the company’s stock valued at $3,619,000 after purchasing an additional 51,075 shares during the period. Royal London Asset Management Ltd. lifted its stake in shares of Avantor by 1.8% in the 3rd quarter. Royal London Asset Management Ltd. now owns 254,888 shares of the company’s stock valued at $6,594,000 after purchasing an additional 4,580 shares during the period. Investment Management Corp of Ontario lifted its stake in shares of Avantor by 49.7% in the 3rd quarter. Investment Management Corp of Ontario now owns 22,585 shares of the company’s stock valued at $584,000 after purchasing an additional 7,500 shares during the period. Finally, Janus Henderson Group PLC lifted its stake in shares of Avantor by 18.2% in the 3rd quarter. Janus Henderson Group PLC now owns 17,692,705 shares of the company’s stock valued at $457,710,000 after purchasing an additional 2,719,615 shares during the period. 95.08% of the stock is owned by institutional investors and hedge funds.

Avantor Stock Performance

Shares of Avantor stock opened at $21.39 on Monday. The company has a market cap of $14.56 billion, a PE ratio of 46.50, a price-to-earnings-growth ratio of 2.57 and a beta of 1.29. Avantor, Inc. has a 52 week low of $19.59 and a 52 week high of $28.00. The business has a 50 day moving average price of $22.78 and a 200-day moving average price of $23.58. The company has a quick ratio of 1.06, a current ratio of 1.54 and a debt-to-equity ratio of 0.84.

Analyst Ratings Changes

AVTR has been the topic of a number of recent analyst reports. Royal Bank of Canada reissued an “outperform” rating and issued a $34.00 price objective on shares of Avantor in a research note on Thursday, September 26th. UBS Group cut their price target on Avantor from $30.00 to $29.00 and set a “buy” rating on the stock in a report on Tuesday, October 8th. Wells Fargo & Company cut their price target on Avantor from $30.00 to $28.00 and set an “overweight” rating on the stock in a report on Monday, October 28th. Robert W. Baird cut their price target on Avantor from $27.00 to $26.00 and set an “outperform” rating on the stock in a report on Monday, October 28th. Finally, Barclays cut their price target on Avantor from $28.00 to $25.00 and set an “overweight” rating on the stock in a report on Friday, October 25th. Three analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $27.69.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.